Economic burden of childhood autism spectrum disorders
- PMID: 24515505
- PMCID: PMC7034397
- DOI: 10.1542/peds.2013-0763
Economic burden of childhood autism spectrum disorders
Abstract
Objective: To estimate the associations between autism spectrum disorder (ASD) diagnoses and service use, caregiver time, and cost outcomes.
Methods: We used national data from the Medical Expenditure Panel Survey linked to the National Health Interview Survey and a study-specific survey to estimate the annual utilization and costs for health care, school, ASD-related therapy, family-coordinated services, as well as caregiver time in children aged 3 to 17 years, with and without parent-reported ASD. Regression analyses estimated the association between ASD diagnosis and cost, controlling for child gender, age, race/ethnicity, insurance status, household income, country region and urban/rural classification, and non-ASD-related illnesses.
Results: Children with parent-reported ASD had higher levels of health care office visits and prescription drug use compared with children without ASD (P < .05). A greater proportion of children in the ASD group used special educational services (76% vs. 7% in the control group, P < .05). After adjusting for child demographic characteristics and non-ASD-associated illnesses, ASD was associated with $3020 (95% confidence interval [CI]: $1017-$4259) higher health care costs and $14,061 (95% CI: $4390-$24,302) higher aggregate non-health care costs, including $8610 (95% CI: $6595-$10,421) higher school costs. In adjusted analyses, parents who reported that their child had ASD did not have significantly higher out-of-pocket costs or spend more time on caregiving activities compared with control parents.
Conclusions: The economic burden associated with ASD is substantial and can be measured across multiple sectors of our society. Previous analyses that focused on health care underestimated this economic burden, particularly for school systems.
Keywords: autism spectrum disorder; cost of illness; health economics.
Conflict of interest statement
Figures
References
-
- Autism and Developmental Disabilities Monitoring Network Surveillance Year 2008 Principal Investigators. Centers for Disease Control and Prevention . Prevalence of autism spectrum disorders—Autism and Developmental Disabilities Monitoring Network, 14 sites, United States, 2008. MMWR Surveill Summ. 2012;61(3):1–19 - PubMed
-
- Blumberg SJ , Bramlett MD , Kogan MD , Schieve LA , Jones JR , Lu MC . Changes in Prevalence of Parent-Reported Autism Spectrum Disorder in School-Aged U.S. Children: 2007 to 2011–2012. Hyattsville, MD: National Center for Health Statistics; 2013. - PubMed
-
- Ganz ML . The lifetime distribution of the incremental societal costs of autism. Arch Pediatr Adolesc Med. 2007;161(4):343–349 - PubMed
-
- Kogan MD , Strickland BB , Blumberg SJ , Singh GK , Perrin JM , van Dyck PC . A national profile of the health care experiences and family impact of autism spectrum disorder among children in the United States, 2005–2006. Pediatrics. 2008;122(6). Available at: www.pediatrics.org/cgi/content/full/122/6/e1149 - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
